---
figid: PMC9634762__JCTH-10-1050-g002
pmcid: PMC9634762
image_filename: JCTH-10-1050-g002.jpg
figure_link: /pmc/articles/PMC9634762/figure/JCTH-D-21-00458-f2/
number: Fig. 2
figure_title: Network pharmacology analysis of the Quzhi formula for NASH treatment
caption: (A) Herb-compound-target network of Quzhi formula. The network includes three
  herbs, 28 compounds, and 165 proteins, forming 426 edges. Node size was positively
  associated with node degree. (B) PPI network of the identified targets. The darker
  and closer to the center of the node indicates a more advanced RANK and a closer
  relationship between the proteins. (C) KEGG pathway analysis of the targets. (D)
  GO function analysis of the targets. C, rhein; CP, Crataegus pinnatifida; CP1, suchilactone;
  CP2, linoleyl acetate; CP3, ursolic acid. CS, Cassiae semen; CS1, aurantio-obtusin;
  CS10, 9,10-dihydroxy-7-methoxy-3-methylene-4H-benzo[g]isochromen-1-one; CS11, obtusin;
  CS12, aloe-emodin; CS13, cassiaside A; CS2, campest-5-en-3beta-ol; CS3, CLR; CS4,
  rubrofusarin-6-beta-gentiobioside; CS5, gluco-obtusifolin; CS6, stigmasterol; CS7,
  rubrofusarin; CS8, toralactone; CS9, quinizarin; PC, Polygonum cuspidatum; PC1,
  physovenine; PC10, polydatin; PC11, resveratrol; PC2, 6,8-dihydroxy-7-methoxyxanthone;
  PC3, (+)-catechin; PC4, luteolin; PC5, quercetin; PC6, physciondiglucoside; PC7,
  torachrysone-8-O-beta-D-(6′-oxayl)-glucoside; PC8, beta-sitosterol; PC9, picralinal,
article_title: Quzhi Formula Alleviates Nonalcoholic Steatohepatitis by Impairing
  Hepatocyte Lipid Accumulation and Inflammation via Bip/eIF2α Signaling.
citation: Yue-Lan Wu, et al. J Clin Transl Hepatol. 2022 Dec 28;10(6):1050-1058.
year: '2022'

doi: 10.14218/JCTH.2021.00458
journal_title: Journal of Clinical and Translational Hepatology
journal_nlm_ta: J Clin Transl Hepatol
publisher_name: XIA & HE Publishing Inc.

keywords:
- Quzhi formula
- NASH
- NAFLD
- ER stress
- Inflammation

---
